Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5419]
News [12581]
Articles [170]
Editorials [5]
Conferences [246]
elearning [17]
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma
Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios...
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic...
Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden
ALSYMPCA trial: Ra-223 effective and well-tolerated for CRPC with symptomatic bone metastases ( Dr Sten Nilsson - Karolinska University Hospital, Stockholm, Sweden )
1 Feb 2014
Review of the latest abstracts from the COU-AA-302 trial
Dr Chris Parker and Prof Stephane Oudard
Review of the latest abstracts from the COU-AA-302 trial ( Dr Chris Parker and Prof Stephane Oudard )
31 Jan 2014
Enzalutamide improves survival in men with metastatic castration-resistant...
Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA
Enzalutamide improves survival in men with metastatic castration-resistant prostate cancer ( Dr Tomasz M. Beer - Oregon Health & Science University, Portland, USA )
31 Jan 2014
Results of orteronel plus prednisone in the TAK-700 trial on mCRPC
Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA
Results of orteronel plus prednisone in the TAK-700 trial on mCRPC ( Dr Robert Dreicer - Cleveland Clinic, Cleveland, USA )
31 Jan 2014
Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant...
Dr Cora Sternberg, Dr Marc Rubin, Dr Heather Payne, Dr Maria De Santis and Dr...
Prostate Cancer Debate 2014: Evolving treatment options in castration-resistant prostate cancer ( Dr Cora Sternberg, Dr Marc Rubin, Dr Heather Payne, Dr Maria De Santis and Dr John Fitzpatrick )
27 Jan 2014
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC)
Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin...
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) ( Dr John Fitzpatrick - Irish Cancer Society & University College Dublin, Dublin, Ireland )
10 Jan 2014
Predictors of response to mCRPC therapy: where do we stand?
Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center...
Predictors of response to mCRPC therapy: where do we stand? ( Dr Ronald de Wit - Rotterdam Cancer Institute, Daniel den Hoed Cancer Center, Netherlands )
10 Jan 2014
Managing mCRPC in daily practice: a pragmatic approach
Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK
Managing mCRPC in daily practice: a pragmatic approach ( Dr Alison Birtle - Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK )
10 Jan 2014
Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel...
J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle
Maximizing survival in metastatic Castration-Resistant Prostate Cancer: panel discussion ( J.M. Fitzpatrick, N. Mottet, R. de Wit, Rotterdam and A Birtle )
10 Jan 2014
Aspirin trialled for breast cancer recurrence prevention
Dr Alistair Ring - Brighton and Sussex Medical School, UK
Aspirin trialled for breast cancer recurrence prevention ( Dr Alistair Ring - Brighton and Sussex Medical School, UK )
20 Dec 2013
Drop in breast cancer mortality in developed countries varies
Dr Donald Berry - MD Anderson Cancer Center, Houston, USA
Drop in breast cancer mortality in developed countries varies ( Dr Donald Berry - MD Anderson Cancer Center, Houston, USA )
19 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation